NUWE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	18.26M
Średni wolumen	1.27M
Kapitalizacja rynkowa	1.14M
EPS	US12542Q700 ( 2024-03-05 )
Następna data zysków	( US12542Q70-0.930 ) 2024-05-14
Last Dividend	US12542Q700 ( N/A )
Next Dividend	US12542Q700 ( N/A )
P/E	-0.0100
ATR14	US12542Q700.00100 (0.59%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Mccormick Michael Kendrick	Buy	20 836	Nonstatutory Stock Option (right to buy)
2024-01-02	Mcdonald David	Buy	11 365	Nonstatutory Stock Option (right to buy)
2024-01-02	Feldshon Archelle Georgiou	Buy	11 365	Nonstatutory Stock Option (right to buy)
2023-11-01	Mcdonald David	Buy	0
2023-11-01	Feldshon Archelle Georgiou	Buy	0

INSIDER POWER
97.91
Last 90 transactions
Buy: 3 285 386 \| Sell: 12 287

Wolumen Korelacja

Długi: -0.21 (neutral)

Krótki: -0.23 (neutral)

Signal:(56.294) Neutral

Nuwellis, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nuwellis, Inc. Korelacja - Waluta/Towar

0.00
( neutral )

0.03
( neutral )

Nuwellis, Inc. Finanse

Annual	2023
Przychody:	US12542Q708.86M
Zysk brutto:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2023
Przychody:	US12542Q708.86M
Zysk brutto:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2022
Przychody:	US12542Q708.54M
Zysk brutto:	US12542Q704.76M (55.66 %)
EPS:	US12542Q70-83.48

FY	2021
Przychody:	US12542Q707.92M
Zysk brutto:	US12542Q704.49M (56.70 %)
EPS:	US12542Q70-285.73

Financial Reports:

No articles found.

Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.